Crystal Engineering of an Anti-HIV Drug Based on the Recognition of Assembling Molecular Frameworks


Autoria(s): MARTINS, Felipe T.; PAPARIDIS, Nikolas; DORIGUETTO, Antonio C.; ELLENA, Javier
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/10/2012

20/10/2012

2009

Resumo

A rational strategy was employed for design of an orthorhombic structure of lamivudine with maleic acid. On the basis of the lamivudine saccharinate structure reported in the literature, maleic acid was chosen to synthesize a salt with the anti-HIV drug because of the structural similarities between the salt formers. Maleic acid has an acid-ionization constant of the anti first proton and an arrangement of their hydrogen bonding functionalities similar to those of saccharin. Likewise, there is a saccharin-like conformational rigidity in maleic acid because of the hydrogen-bonded ring formation and the Z-configuration around the C=C double bond. As was conceivably predicted, lamivudine maleate assembles into a structure whose intermolecular architecture is related to that of saccharinate salt of the drug. Therefore, a molecular framework responsible for crystal assembly into a lamivudine saccharinate-like structure could be recognized in the salt formers. Furthermore, structural correlations and structure-solubility relationships were established for lamivudine maleate and saccharinate. Although there is a same molecular framework in maleic acid and saccharin, these salt formers are Structurally different in some aspects. When compared to saccharin, neither out-of-plane SO(2) oxygens nor a benzene group occur in maleic acid. Both features could be related to higher solubility of lamivudine maleate. Here, we also anticipate that multicomponent molecular crystals of lamivudine with other salt formers possessing the molecular framework responsible for crystal assembly can be engineered successfully.

Centro de Equivalencia Farmaceutica (Nucleo de Controle de Qualidade de Farmacos e Medicamentos, Universidade Federal de Alfenas, CEFAR-NCQ/UNIFAL-MG)

Centro de Equivalencia Farmaceutica (Nucleo de Controle de Qualidade de Farmacos e Medicamentos, Universidade Federal de Alfenas, CEFAR-NCQ/UNIFAL-MG)

Brazilian Research Council CNPq (Conselho Nacional de Desenvolvimento Cientifico c Tecnologico)

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo[2007/07185-5]

FAPEMIG (Fundacao de Amparo A Pesquisa do Estado de Minas Gerais[APQ-2011-5.02/07]

Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)

Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)

FAPEMIG (Fundacao de Amparo A Pesquisa do Estado de Minas Gerais[APQ-6010-5.02/07]

FAPEMIG (Fundacao de Amparo A Pesquisa do Estado de Minas Gerais[APQ-02685-09]

Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)[PNPD2008]

Identificador

CRYSTAL GROWTH & DESIGN, v.9, n.12, p.5283-5292, 2009

1528-7483

http://producao.usp.br/handle/BDPI/29907

10.1021/cg900790f

http://dx.doi.org/10.1021/cg900790f

Idioma(s)

eng

Publicador

AMER CHEMICAL SOC

Relação

Crystal Growth & Design

Direitos

restrictedAccess

Copyright AMER CHEMICAL SOC

Palavras-Chave #CO-CRYSTALS #SOLUBILITY #SALTS #POLYMORPHISM #LAMIVUDINE #COCRYSTALS #Chemistry, Multidisciplinary #Crystallography #Materials Science, Multidisciplinary
Tipo

article

original article

publishedVersion